Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dieter Depisch"'
Autor:
Matthias E Sporer, Martin Aman, Konstantin D Bergmeister, Dieter Depisch, Katharina M Scheuba, Ewald Unger, Bruno K Podesser, Oskar C Aszmann
Publikováno v:
Neural Regeneration Research, Vol 17, Iss 5, Pp 1088-1095 (2022)
Clinically, peripheral nerve reconstructions in neonates are most frequently applied in brachial plexus birth injuries. Most surgical concepts, however, have investigated nerve reconstructions in adult animal models. The immature neuromuscular system
Externí odkaz:
https://doaj.org/article/709bdd52e5424d218d14a39b72660550
Autor:
Christoph Tausch, Raimund Jakesz, Michael Stierer, Susanne Taucher, Hans-Jörg Mischinger, Brigitte Mlineritsch, Werner Kwasny, Dieter Depisch, Hellmut Samonigg, Ernst Kubista, P. Steindorfer, Michael Seifert, Rainer-Christian Menzel, Hubert Hausmaninger, Michael Gnant, R. Kolb
Publikováno v:
Annals of Surgery. 237:556-564
Scientifically, it has been well established that breast-conserving treatment (BCT) in patients with breast cancer does not impair overall prognosis as compared to mastectomy. Several randomized clinical trials in the past two decades have shown that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091520242a6d5c029aa5df70b7b316ae
https://doi.org/10.1097/01.sla.0000059990.43981.4e
https://doi.org/10.1097/01.sla.0000059990.43981.4e
Autor:
Herbert Ulrich-Pur, Bruno Schneeweiss, Karin Haider, Renate Greul, Josef Funovics, Gwendolyn Krauss, Markus Raderer, Gabriela V. Kornek, Dieter Depisch, Werner Scheithauer, Werner Kwasny
Publikováno v:
Cancer. 88:2505-2511
BACKGROUND Although the novel cytidine analog gemcitabine has shown superior antitumor activity compared with weekly bolus 5-fluorouracil in patients with advanced pancreatic carcinoma, further improvements of therapeutic results are warranted. The c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21498d3f35eb97cac7c0aef31b46a737
https://doi.org/10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co
https://doi.org/10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co
Autor:
Daniela Kandioler, Dieter Depisch, Gerwin Heller, Sabine Zöchbauer-Müller, Irene Newsham, Walter Berger, Wolfgang Stiglbauer, Robert Pirker, Christoph C. Zielinski, Eva Maria Markis-Ritzinger, Joseph Geradts, Martin Filipits, Barbara Ziegler
Publikováno v:
Breast cancer research and treatment. 103(3)
TSLC1 and DAL-1 are tumor suppressor genes involved in cell adhesion. In this study, we examined the expression and methylation pattern of these genes in breast cancer cell lines and primary breast carcinomas. TSLC1 expression was lost in 5 of 8 (63%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da293380d71df98ce08ef8a9ed63183e
https://pubmed.ncbi.nlm.nih.gov/17260099
https://pubmed.ncbi.nlm.nih.gov/17260099
Autor:
Gabriela V, Kornek, Karin, Haider, Werner, Kwasny, Markus, Raderer, Birgit, Schüll, Thomas, Payrits, Dieter, Depisch, Erwin, Kovats, Fritz, Lang, Werner, Scheithauer
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(5)
A multicenter Phase II trial was performed to investigate the efficacy and tolerance of combined docetaxel and gemcitabine +/- recombinant human granulocyte colony-stimulating factor (G-CSF) in patients with metastatic breast cancer.Fifty-two patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e1145a12244f152790282011dec5f38
https://pubmed.ncbi.nlm.nih.gov/12006518
https://pubmed.ncbi.nlm.nih.gov/12006518
Autor:
Gabriela V. Kornek, Werner Kwasny, Karin Haider, M. Penz, Tomas Salek, Werner Scheithauer, Markus Raderer, Herbert Ulrich-Pur, Dieter Depisch
Publikováno v:
Cancer. 91(7)
BACKGROUND Oxaliplatin and raltitrexed both are active anticancer agents in the treatment of patients with advanced colorectal carcinoma: They have different mechanisms of action and toxicity profiles and have shown at least additive effects in exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2765678b91c71623b1a301e489c7176f
https://pubmed.ncbi.nlm.nih.gov/11283925
https://pubmed.ncbi.nlm.nih.gov/11283925
Autor:
Werner Scheithauer, Gabriela Kornek, Harald Rosen, Werner Kwasny, Franz Schulz, Christian Sebesta, Dieter Depisch
Publikováno v:
Cancer. 71(7)
Background. To determine the maximum tolerated dose of epirubicin for use in combination with 5-fluorouracil (5-FU) and low-dose leucovorin (LV), a Phase I–II trial was conducted in 37 patients with advanced gastric carcinoma. Methods. The doses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a078a685125a497c0aa7e79333925d68
https://pubmed.ncbi.nlm.nih.gov/8453539
https://pubmed.ncbi.nlm.nih.gov/8453539
Autor:
Joseph Geradts, Irene Newsham, Martin Filipits, Eva-Maria Markis-Ritzinger, Daniela Kandioler, Walter Berger, Wolfgang Stiglbauer, Dieter Depisch
Publikováno v:
Breast Cancer Research & Treatment; Jul2007, Vol. 103 Issue 3, p283-291, 9p